CBD for Pets: What the Research Says and What to Know Before Buying
CBD in Pet Products: Separating Signal from Noise
The CBD pet product market has exploded, with products claiming to address everything from arthritis to anxiety to cancer. The marketing is often far ahead of the science. A balanced look at what research currently shows — and doesn't show — about CBD for pets is essential for making an informed decision in a crowded, largely unregulated market.
What CBD Is
CBD (cannabidiol) is a non-psychoactive compound derived from hemp (Cannabis sativa). Unlike THC (tetrahydrocannabinol), CBD does not cause intoxication. The compound interacts with the endocannabinoid system (ECS), a regulatory signaling network present in all mammals that influences pain, inflammation, mood, appetite, and immune function. This is the biological rationale for potential therapeutic effects.
What the Research Shows (As of 2024-2025)
Osteoarthritis (dogs): This is where the best evidence exists. A 2018 Cornell University study found that 2 mg/kg of CBD oil twice daily significantly decreased pain scores and improved mobility in arthritic dogs without clinically significant side effects. Several subsequent studies have produced similar findings. This is the most promising clinical application currently supported by research.
Epilepsy (dogs): A Colorado State University study found that 89% of dogs who received CBD in a clinical trial had a reduction in seizure frequency. However, the effect was added to, not replacing, existing anti-seizure medications. CBD is not yet approved as a standalone epilepsy treatment in dogs.
Anxiety: Commonly marketed application with limited controlled trial evidence in veterinary populations. Some evidence of acute anxiety reduction in dogs; robust controlled trials are lacking.
Cats: Research specifically in cats is extremely limited. Cats have different ECS receptor distribution and hepatic (liver) metabolism than dogs, and should not be assumed to respond equivalently.
Safety Considerations
CBD appears to be well tolerated in dogs at appropriate doses in the studies conducted. Common side effects include sedation and GI upset at higher doses. One important concern: CBD is metabolized by the liver enzyme CYP450, and can alter the metabolism of other drugs. If your dog is on other medications, discuss CBD with your veterinarian before starting.
THC toxicity is a different issue entirely. Full-spectrum CBD products may contain trace THC; products with THC levels that are safe for humans can still cause intoxication in pets. Pets should never receive products containing meaningful THC levels. Hemp-derived CBD products with less than 0.3% THC are the standard, but verification through a certificate of analysis (COA) from a third-party lab is important.
Regulatory Status and Quality Issues
The FDA has not approved any CBD products for use in veterinary patients (with the exception of Epidiolex, which is approved for human epilepsy). This means the CBD pet product market is largely unregulated. Studies analyzing commercial CBD products have found that many contain significantly less CBD than labeled, some contain none at all, and a few contain more than labeled or more THC than advertised. Always look for products with a current third-party certificate of analysis (COA) confirming CBD content and THC levels, and from a company that is transparent about their testing practices.